ATE309355T1 - Gas1-polypeptide - Google Patents

Gas1-polypeptide

Info

Publication number
ATE309355T1
ATE309355T1 AT00962353T AT00962353T ATE309355T1 AT E309355 T1 ATE309355 T1 AT E309355T1 AT 00962353 T AT00962353 T AT 00962353T AT 00962353 T AT00962353 T AT 00962353T AT E309355 T1 ATE309355 T1 AT E309355T1
Authority
AT
Austria
Prior art keywords
protein
gas1
lethal
cell
sequence encoding
Prior art date
Application number
AT00962353T
Other languages
English (en)
Inventor
Walter Herman Maria Lou Luyten
Jose Ramon Naranjo
Britt Mellstroem
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Application granted granted Critical
Publication of ATE309355T1 publication Critical patent/ATE309355T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Genetics & Genomics (AREA)
  • Neurology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Diabetes (AREA)
  • Psychology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Physics & Mathematics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Plant Pathology (AREA)
AT00962353T 1999-08-24 2000-08-21 Gas1-polypeptide ATE309355T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99306702 1999-08-24
PCT/EP2000/008182 WO2001014549A1 (en) 1999-08-24 2000-08-21 Gas1 polypeptides

Publications (1)

Publication Number Publication Date
ATE309355T1 true ATE309355T1 (de) 2005-11-15

Family

ID=8241594

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00962353T ATE309355T1 (de) 1999-08-24 2000-08-21 Gas1-polypeptide

Country Status (14)

Country Link
US (1) US20080085861A1 (de)
EP (1) EP1212421B1 (de)
JP (1) JP2003507067A (de)
KR (1) KR20020019572A (de)
AT (1) ATE309355T1 (de)
AU (1) AU783872B2 (de)
CA (1) CA2382674A1 (de)
DE (1) DE60023921T2 (de)
ES (1) ES2253251T3 (de)
IL (1) IL148311A0 (de)
NO (1) NO20020916L (de)
NZ (1) NZ516870A (de)
WO (1) WO2001014549A1 (de)
ZA (1) ZA200201478B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX361195B (es) * 2014-05-23 2018-11-13 Centro De Investig Y De Estudios Avanzados Del I P N Sistema de nanoparticulas genicas con efecto apoptotico y especificidad tumoral para el tratamiento de cancer.

Also Published As

Publication number Publication date
CA2382674A1 (en) 2001-03-01
AU783872B2 (en) 2005-12-15
US20080085861A1 (en) 2008-04-10
JP2003507067A (ja) 2003-02-25
AU7411700A (en) 2001-03-19
KR20020019572A (ko) 2002-03-12
ES2253251T3 (es) 2006-06-01
DE60023921T2 (de) 2006-08-10
NO20020916D0 (no) 2002-02-25
DE60023921D1 (en) 2005-12-15
ZA200201478B (en) 2004-04-28
NO20020916L (no) 2002-04-24
EP1212421A1 (de) 2002-06-12
EP1212421B1 (de) 2005-11-09
WO2001014549A1 (en) 2001-03-01
IL148311A0 (en) 2002-09-12
NZ516870A (en) 2003-10-31

Similar Documents

Publication Publication Date Title
ATE485371T1 (de) Varianten des menschlichen koagulationsfaktors vii
BRPI0412401A (pt) polipeptìdeos da amilase exoespecìficos, ácidos nucléicos que codificam tais polipeptìdeos e usos dos mesmos
NO20031129D0 (no) Varianter av human koagulasjonsfaktor VII
WO2003104270A3 (en) GENES OF DUDULINE 2, EXPRESSION PRODUCTS, NON-HUMAN ANIMAL MODEL: USES IN HUMAN HEMATOLOGICAL DISEASES
MXPA02005337A (es) Control biologico por sistema generico letal, dominante, condicional.
DE60330923D1 (de) Menschliche Koagulationsfaktor VII Polypeptide
EA200600868A1 (ru) Гидрогенолиз сахарного сырья
EE04685B1 (et) Ravimi l„bimiskiirust kontrolliv membraan v?i maatriks
BR0009170A (pt) ácidos nucléicos akt, polipeptìdeos e uso dos mesmos
DK1290160T3 (da) Humane Pellino-polypeptider
ATE309355T1 (de) Gas1-polypeptide
ATE327253T1 (de) Proteine und nukleinsäuremoleküle des kopfes, des nervenkords, der tieferen darmabschnitte und des malpighi-gefässes des flohs und ihre verwendungen
PT928197E (pt) Utilizacao de proteinas como agentes contra doencas de natureza autoimunitaria
DK1075523T3 (da) Strukturelle proteiner hos fiskepankreassygdomsvirus og anvendelser deraf
WO2001045738A3 (en) Use of heat shock proteins to enhance production of chemokines by a cell
ATE322906T1 (de) Verwendung von langem pentraxin ptx3 zur behanlung von durch geänderte aktivität des fgf-2 wachstumsfaktors hervorgerufene krankheiten
DK1339853T3 (da) Isolerede luciferaser og deres anvendelse
DE69732246D1 (de) Gewebespezifische expression des retinoblastoma-proteins
NO995692D0 (no) Nye BPC-peptidsalter med organbeskyttende aktivitet, metoden for deres fremstilling og deres anvendelse
DK0774004T3 (da) DNA-sekvens, som koder for de humane proteiner Tx og Ty, der er beslægtede med Interleukin-1betakonverterende enzym
NO952601L (no) Oligonukleotider for inhibering av ekspresjon av isoprenylprotein-transferaser
NO20016089D0 (no) Nuklein- og proteinsyrer som svarer til det humane gen ABC1
FI20000182A0 (fi) Nukleotidisekvenssien käyttö proteiinisynteesin ja proteiinien ilmentämisen lisäämiseksi
IT1316921B1 (it) Organo bioartificiale per ospitare cellule animali e/o umane.
DE60129228D1 (de) Humane 7-transmembranproteine und dafür codierende polynukleotide

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties